Our Products

Diagram 5.png

NG-01-MS (NG-1)

NG-1 is the company’s lead product. The initial intended indication of NG-1 is for the treatment of progressive Multiple Sclerosis.

NG-1 has neuroprotective and neuro-regenerative properties. NG-1 can prevent neurons and oligodendrocytes from apoptosis via the release of trophic and anti-apoptotic molecules (NGF, BDNF, and others), and has anti-proliferative effects on microglial cells and astrocytes, resulting in the induction of a neuroprotective microenvironment.


NG-1 also promotes the proliferation and maturation of local neural precursor cells, leading to their differentiation into mature neurons and oligodendrocyte. NG-1 suppresses the proliferation and reduce the pro-inflammatory cytokine secretions mediated by several cells of the immune system such as T and B lymphocytes, NK cells and dendritic cells.


NG-1 modulates the immune response and promotes regeneration of neuronal cells in the CNS


NG-2 is the company’s second product which is still under development. NG-2 has enhanced neuroprotective and neuro-regenerative properties and has the potential to differentiate and acquire neuronal cell properties.


Intended indications are ALS, Alzheimer’s and other diseases of the central nervous system.

Diagram 6.png

Mode of Action

diagram 2.png
diagram 3.png